George Sutton's questions to SelectQuote (SLQT) leadership • Q4 2025
Question
George Sutton from Craig-Hallum Capital Group LLC asked about the shift in tone regarding SelectRx growth from cautious last quarter to more optimistic, questioned the company's AEP hiring plans, and inquired about the role of AI in enhancing customer service. He also sought details on the expected contribution from the Select Patient Management segment in fiscal 2026.
Answer
President Robert Grant clarified the focus has shifted from rapid membership growth to EBITDA growth and margin expansion, projecting over 20% revenue growth for SelectRx. CEO Tim Danker noted expectations for elevated plan disruption during AEP. Robert Grant then detailed that AI is used to make simple interactions more efficient, saving agent time and citing a 25% reduction in enrollment time, but will not replace complex agent conversations. He added that Select Patient Management is not expected to provide meaningful EBITDA in fiscal 2026 but remains a key long-term opportunity.